

![]() |
Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial |
|
Authors | ![]() | |
Collaboration | With : Mclin, Valérie Anne | |
Published in | JAMA (Journal of the American Medical Association). 2014, vol. 311, no. 17, p. 1750-9 | |
Abstract | Biliary atresia is the most common cause of end-stage liver disease in children. Controversy exists as to whether use of steroids after hepatoportoenterostomy improves clinical outcome. | |
Keywords | Administration, Oral — Adrenal Cortex Hormones/administration & dosage/adverse effects — Biliary Atresia/drug therapy/surgery — Bilirubin/blood — Double-Blind Method — Drainage/methods — Female — Humans — Infant — Infusions, Intravenous — Male — Methylprednisolone/administration & dosage/adverse effects — Portoenterostomy, Hepatic — Prednisolone/administration & dosage/adverse effects — Survival Analysis — Treatment Outcome | |
Identifiers | PMID: 24794368 | |
Full text | ||
Structures | ||
Research group | Développement du tube digestif chez les vertébrés (900) | |
Citation (ISO format) | BEZERRA, Jorge A et al. Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial. In: JAMA (Journal of the American Medical Association), 2014, vol. 311, n° 17, p. 1750-9. doi: 10.1001/jama.2014.2623 https://archive-ouverte.unige.ch/unige:55234 |